Fudan University
Clinical trials sponsored by Fudan University, explained in plain language.
-
Microplastics making you fat? probiotic pill shows promise in new study
Disease control CompletedThis study looked at whether tiny plastic particles (microplastics) we encounter daily might contribute to obesity and gut problems. Researchers gave 96 overweight or obese adults either a probiotic supplement or a placebo to see if the probiotic could reduce the harmful effects …
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
New combo therapy shows promise for uterine condition in obese women
Disease control CompletedThis study tested whether adding a diabetes drug (polyethylene glycol loxenatide) to a hormone-releasing IUD (LNG-IUS) helps women with a precancerous uterine condition called endometrial atypical hyperplasia. The 30 participants were all obese and wanted to preserve their fertil…
Phase: PHASE2, PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New pill combo aims to prevent return of early breast cancer
Disease control CompletedThis study tested whether taking oral chemotherapy pills (vinorelbine or capecitabine) along with the targeted drug trastuzumab can help prevent breast cancer from coming back in women with small, HER2-positive tumors that have not spread to lymph nodes. The 182 participants took…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Polyphenol power: could a daily supplement fight Pollution's harm?
Disease control CompletedThis study tested whether a mix of 43 plant compounds (polyphenols) can reduce health harm from environmental pollutants like microplastics. 98 healthy adults took either the supplement or a placebo for a period. Researchers measured changes in gut health, inflammation, blood sug…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
Cancer cocktail shows promise in head and neck tumors
Disease control CompletedThis study tested a combination of three drugs—camrelizumab, cetuximab, and chemotherapy—as a first treatment for people with head and neck cancer that has come back or spread. 41 patients received the drugs to see how many would have their tumors shrink or disappear. The goal is…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
New hope for rare immune disease: drug combo shows promise in small study
Disease control CompletedThis study tested a combination of two drugs—interferon-gamma monoclonal antibody and dexamethasone—in 22 adults with a severe immune condition called refractory secondary HLH. The goal was to see if the treatment helps patients recover and how safe it is. Participants received t…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
Less is more? new surgery for rare pancreatic tumor shows promise
Disease control CompletedThis study looked at a less invasive surgery for a rare, low-grade pancreatic tumor called solid pseudopapillary neoplasm (SPN). The goal was to see if removing less of the pancreas is safe and if removing nearby lymph nodes is necessary. The study included 708 patients and track…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
Could a simple anesthesia change boost pancreatic cancer survival?
Disease control CompletedThis study looked at whether using epidural anesthesia (a numbing shot in the back) during pancreatic cancer surgery helps people live longer and stay cancer-free longer. About 540 adults having surgery for pancreatic cancer took part. The goal was to see if this type of pain con…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 17, 2026 12:03 UTC
-
New drug cocktail shows promise in preventing bile duct cancer return after surgery
Disease control CompletedThis study tested a combination of three drugs (capecitabine, lenvatinib, and tislelizumab) given after surgery to 65 adults with biliary tract cancer. The goal was to see if this treatment could help keep the cancer from coming back. The results focus on how long patients lived …
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Herbal hope: new combo therapy targets advanced pancreatic cancer
Disease control CompletedThis study tested whether adding a Chinese herbal formula (QingyiHuaji) to standard chemotherapy helps people with stage IV pancreatic cancer live longer. About 305 adults with advanced pancreatic cancer were randomly assigned to receive either the herbal formula plus chemo or a …
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Heated chemo drug tested for colorectal cancer safety
Disease control CompletedThis early-phase trial tested whether a heated chemotherapy drug called raltitrexed is safe and tolerable for people with colorectal cancer. 30 patients received the treatment directly into their abdomen during surgery. The goal was to find the best dose with the fewest side effe…
Phase: PHASE1 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Promising combo shrinks lung tumors before surgery in early trial
Disease control CompletedThis study tested a drug called serplulimab combined with chemotherapy for people with stage II-IIIA non-small cell lung cancer that could be removed by surgery. The treatment was given before and after surgery to see if it could shrink tumors and improve outcomes. 30 participant…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
New combo reduces steroid use in chemo side effect prevention
Symptom relief CompletedThis study tested whether using less dexamethasone (a steroid) along with two other anti-nausea drugs (NEPA and olanzapine) works as well as the standard full-dose steroid approach. 644 adults receiving strong chemotherapy were enrolled. The goal was to see if the reduced-steroid…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 22, 2026 12:04 UTC
-
Nerve block may ease pain after breast cancer reconstruction
Symptom relief CompletedThis study tested a nerve block called the erector spinae plane block to see if it reduces pain after breast cancer surgery with implant reconstruction. 100 women scheduled for this surgery took part. The goal was to measure pain levels and recovery quality after the operation.
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 18, 2026 11:51 UTC
-
No more bandage changes? study finds skipping dressings after gut surgery could be just as safe
Symptom relief CompletedThis study tested whether leaving surgical wounds uncovered after gastrointestinal cancer surgery is as safe as changing the dressing every two days. Over 1,100 adults who had elective surgery for gastrointestinal cancer were randomly assigned to either no dressing changes after …
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 15, 2026 19:09 UTC
-
Herbal granule shows promise in easing kidney harm from cancer drugs
Symptom relief CompletedThis study looked at whether Huaier Granule, a traditional Chinese medicine, can reduce protein in the urine—a sign of kidney damage—caused by anti-angiogenesis targeted therapy in 76 adults with advanced liver or bile duct cancer. Participants took the granule for 8 weeks, and r…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 09, 2026 12:07 UTC
-
Ozone exposure alters skin chemistry, study finds
Knowledge-focused CompletedThis study from Fudan University tested how ozone, a common air pollutant, affects skin health. Forty healthy adults had their forearms exposed to either ozone or clean air for two hours. Researchers measured changes in skin chemicals, hydration, and moisture loss to see how poll…
Phase: NA • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC
-
Breakfast boost: fruits and veggies may sharpen young minds
Knowledge-focused CompletedThis study looked at whether giving 7-11 year old children in Shanghai a daily breakfast with fruits and vegetables could improve their thinking, mood, and attention. Over 250 kids took part, receiving a healthy breakfast every day for 12 weeks. Researchers measured changes in IQ…
Phase: NA • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC
-
New model could help spot High-Risk COPD patients with hidden muscle loss
Knowledge-focused CompletedThis completed study from Fudan University looked at 200 older adults with COPD who also have sarcopenic obesity — a condition where people have both low muscle mass and excess body fat. Researchers used a device called InBody S10 to measure body composition and phase angle, aimi…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:00 UTC
-
Can targeted radiation boost lung cancer treatment? 4000-patient study seeks answers.
Knowledge-focused CompletedThis study looked at 4000 people with advanced lung cancer who had a specific gene mutation (EGFR) and were taking a targeted pill. The goal was to find the best time to add focused radiation to shrink any remaining tumors. Researchers tracked when tumors shrank the most and wher…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
AI predicts stomach cancer comeback: new hope for personalized treatment
Knowledge-focused CompletedThis study used artificial intelligence to predict if stomach cancer will come back after surgery. Researchers analyzed data from 5000 patients to create a model that can identify who is at high risk for early recurrence. This tool can help doctors choose the best follow-up treat…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
Real-world study examines quality of life and compliance in young breast cancer patients on hormone-blocking therapy
Knowledge-focused CompletedThis study involved 562 premenopausal women in China with hormone receptor-positive breast cancer who received a GnRHa injection to suppress ovarian function after surgery. Researchers measured their quality of life and how well they followed the treatment plan using questionnair…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Colon polyp count linked to future cancer risk, study finds
Knowledge-focused CompletedThis study looked at nearly 3,000 people who had non-advanced colon polyps (small, low-risk growths) found during their first screening colonoscopy. Researchers wanted to see if having more of these polyps increased the chance of developing advanced growths or cancer later. The g…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Real-World data reveals immunotherapy Combo's impact on esophageal cancer
Knowledge-focused CompletedThis study analyzed medical records from 1197 patients in China with advanced esophageal cancer who received immunotherapy (anti-PD-1) plus chemotherapy as their first treatment. The goal was to see how long patients lived and how long the cancer stayed under control in everyday …
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC